UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 974

Sortiert nach

The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia

Diabetes, obesity & metabolism, 2012-01, Vol.14 (1), p.5-14

2012

Link zum Volltext

Verfügbarkeit prüfen

Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies

Diabetic medicine, 2009-12, Vol.26 (12), p.1185-1192

Del Prato, S.

2009

Link zum Volltext

Verfügbarkeit prüfen

Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data

Diabetes, obesity & metabolism, 2015-06, Vol.17 (6), p.581-590

2015

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular and heart failure safety profile of vildagliptin: a meta-analysis of 17000 patients

Diabetes, obesity & metabolism, 2015-11, Vol.17 (11), p.1085-1092

2015

Link zum Volltext

Verfügbarkeit prüfen

Durability of the efficacy and safety of alogliptin compared with glipizide in type 2 diabetes mellitus: a 2-year study

Diabetes, obesity & metabolism, 2014-12, Vol.16 (12), p.1239-1246

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial

Diabetes, obesity & metabolism, 2011-03, Vol.13 (3), p.258-267

2011

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea

Diabetes, obesity & metabolism, 2014-05, Vol.16 (5), p.403-409

2014

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion

Diabetologia, 2008-04, Vol.51 (4), p.615-622

2008

Link zum Volltext

Verfügbarkeit prüfen

The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: A consensus view of Italian diabetes experts using the Delphi method

Nutrition, metabolism, and cardiovascular diseases, 2019-05, Vol.29 (5), p.421-431

2019

Link zum Volltext

Verfügbarkeit prüfen

Durability of glycaemic efficacy over 2years with dapagliflozin versus glipizide as add-on therapies in patients whose type 2 diabetes mellitus is inadequately controlled with metformin

Diabetes, obesity & metabolism, 2014-11, Vol.16 (11), p.1111-1120

2014

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular and heart failure safety profile of vildagliptin: a meta-analysis of 17 000 patients

Diabetes, obesity & metabolism, 2015-11, Vol.17 (11), p.1085-1092

2015

Link zum Volltext

Verfügbarkeit prüfen

Loss of early insulin secretion leads to postprandial hyperglycaemia

Diabetologia, 2003-03, Vol.46 Suppl 1 (S1), p.M2-M8

Del Prato, S

2003

Link zum Volltext

Verfügbarkeit prüfen

Dipeptidyl peptidase-4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes

Diabetes, obesity & metabolism, 2015-02, Vol.17 (2), p.107-115

2015

Link zum Volltext

Verfügbarkeit prüfen

Baseline characteristics in the VERIFY study: a randomized trial assessing the durability of glycaemic control with early vildagliptin‐metformin combination in newly diagnosed Type 2 diabetes

Diabetic medicine, 2019-04, Vol.36 (4), p.505-513

2019

Link zum Volltext

Verfügbarkeit prüfen

Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials

Nutrition, metabolism, and cardiovascular diseases, 2015-10, Vol.25 (10), p.898-905

2015

Link zum Volltext

Verfügbarkeit prüfen

Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients

Diabetologia, 2005-02, Vol.48 (2), p.282-289

2005

Link zum Volltext

Verfügbarkeit prüfen

Tailoring treatment to the individual in type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes Management

International journal of clinical practice (Esher), 2010-02, Vol.64 (3), p.295-304

2010

Link zum Volltext

Verfügbarkeit prüfen

Intermediate metabolism in normal pregnancy and in gestational diabetes

Diabetes/metabolism research and reviews, 2003-07, Vol.19 (4), p.259-270

2003

Link zum Volltext

Verfügbarkeit prüfen

Differential effects of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide and metformin on pancreatic β-cell and insulin sensitivity during a standardized test meal in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2016-08, Vol.18 (8), p.834-839

2016

Link zum Volltext

Verfügbarkeit prüfen

In search of normoglycaemia in diabetes: controlling postprandial glucose

International Journal of Obesity, 2002-09, Vol.26 Suppl 3 (S3), p.S9-S17

Del Prato, S

2002

Link zum Volltext

Verfügbarkeit prüfen

Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy

Diabetes, obesity & metabolism, 2015-02, Vol.17 (2), p.202-206

2015

Link zum Volltext

Verfügbarkeit prüfen

Megatrials in type 2 diabetes. From excitement to frustration?

Diabetologia, 2009-07, Vol.52 (7), p.1219-1226

Del Prato, S

2009

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of linagliptin according to patient baseline characteristics: A pooled analysis of three phase 3 trials

Nutrition, metabolism, and cardiovascular diseases, 2016-10, Vol.26 (10), p.886-892

2016

Link zum Volltext

Verfügbarkeit prüfen

Linagliptin treatment in subjects with type 2 diabetes with and without mild-to-moderate renal impairment

Diabetes, obesity & metabolism, 2014-06, Vol.16 (6), p.560-568

2014

Link zum Volltext

Verfügbarkeit prüfen

Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double-blind, active-controlled, parallel group, multinational clinical trial

Diabetes, obesity & metabolism, 2015-02, Vol.17 (2), p.136-144

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 974

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(850)
Mit Volltextzugriff
(871)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(564)
Life Sciences & Biomedicine
(529)
Humans
(512)
Endocrinology & Metabolism
(332)
Female
(271)
Male
(249)
Diabetes
(227)
Middle Aged
(207)
Adult
(200)
Biological And Medical Sciences
(193)
Medical Sciences
(180)
Diabetes Mellitus, Type 2 - Drug Therapy
(138)
Diabetes Mellitus
(130)
Type 2 Diabetes
(125)
Aged
(118)
Blood Glucose - Metabolism
(113)
Insulin
(104)
Endocrinopathies
(103)
Glucose
(95)
Endocrine Pancreas. Apud Cells
(94)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia

Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies

Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data

Cardiovascular and heart failure safety profile of vildagliptin: a meta-analysis of 17000 patients

Durability of the efficacy and safety of alogliptin compared with glipizide in type 2 diabetes mellitus: a 2-year study

Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial

Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea

Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion

The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: A consensus view of Italian diabetes experts using the Delphi method

Durability of glycaemic efficacy over 2years with dapagliflozin versus glipizide as add-on therapies in patients whose type 2 diabetes mellitus is inadequately controlled with metformin

Cardiovascular and heart failure safety profile of vildagliptin: a meta-analysis of 17 000 patients

Loss of early insulin secretion leads to postprandial hyperglycaemia

Dipeptidyl peptidase-4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes

Baseline characteristics in the VERIFY study: a randomized trial assessing the durability of glycaemic control with early vildagliptin‐metformin combination in newly diagnosed Type 2 diabetes

Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials

Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients

Tailoring treatment to the individual in type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes Management

Intermediate metabolism in normal pregnancy and in gestational diabetes

Differential effects of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide and metformin on pancreatic β-cell and insulin sensitivity during a standardized test meal in patients with type 2 diabetes

In search of normoglycaemia in diabetes: controlling postprandial glucose

Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy

Megatrials in type 2 diabetes. From excitement to frustration?

Efficacy and safety of linagliptin according to patient baseline characteristics: A pooled analysis of three phase 3 trials

Linagliptin treatment in subjects with type 2 diabetes with and without mild-to-moderate renal impairment

Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double-blind, active-controlled, parallel group, multinational clinical trial

Suchergebnisse filtern